Related Experiment Video
Updated: Aug 16, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
Does c-erbB-2 play a role in the first steps of lung carcinogenesis?
Anne-Pascale Meert1, Benoit Martin, Jean-Marc Verdebout
1F.N.R.S (Fonds National de la Recherche Scientifique); Bruxelles, Belgique. ap.meert@bordet.be
Background:
The 1999 WHO/IASLC histological classification of preneoplastic bronchial lesions has been shown to be reproducible, but little is known about its biological significance. The EGFR expression rate increases from normal epithelium to carcinoma in situ (CIS) with a significant difference between mild versus severe dysplasia. C-erbB-2, another member of the erbB family, is overexpressed in lung carcinomas, suggesting that this mechanism may play a role in carcinogenesis. We evaluated the correspondence between the morphological changes of the bronchial epithelium and the c-erbB-2 expression.
Materials And Methods:
Nine normal bronchial epithelia, 16 hyperplasia, 12 metaplasia, 12 mild dysplasia, 8 severe dysplasia, 11 CIS and 6 microinvasive tumours were evaluated. Immunostaining was performed using anti-c-erbB-2 antibodies (clone CBI ).
Results:
No immunostaining was found whatever the bronchial lesions evaluated.
Conclusion:
C-erbB-2 does not seem to be involved in the first step of carcinogenesis of squamous cell carcinoma. These findings suggest that there is no place for chemoprevention by anti-c-erbB-2 drugs such as trastuzumab in lung cancer.
Related Concept Videos
Mitogens and the Cell Cycle
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer Prevention
Some...
Negative Regulator Molecules
Mutagenicity and Carcinogenicity
MAPK Signaling Cascades

